Metabolic Syndrome and 16-Year Cognitive Decline in Community-Dwelling Older Adults

Annals of Epidemiology

Volumn 22, Issue 5, 2012, Pages 310-317

  McEvoy, Linda K ^a   Laughlin, Gail A ^b   Barrett Connor, Elizabeth ^b   Bergstrom, Jaclyn ^b   Kritz Silverstein, Donna ^b   Der Martirosian, Claudia ^b   von Mühlen, Denise ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Cognition; Diabetes; Executive Function; Inflammation; Memory

Indexed keywords

BIOLOGICAL MARKER;

AGED; ARTICLE; COGNITIVE DEFECT; COMMUNITY SAMPLE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RECALL; RISK ASSESSMENT; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK; RISK FACTORS;

EID: 84860233249     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2011.12.003     Document Type: Article

References (42)

1. Yaffe K. Metabolic syndrome and cognitive decline. Curr Alzheimer Res 2007, 4:123-126.
2. Komulainen P., Lakka T.A., Kivipelto M., Hassinen M., Helkala E.L., Haapala I., et al. Metabolic syndrome and cognitive function: A population-based follow-up study in elderly women. Dement Geriatr Cogn Disord 2007, 23:29-34.
3. Schuur M., Henneman P., van Swieten J.C., Zillikens M.C., de Koning I., Janssens A.C., et al. Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study. Eur J Epidemiol 2010, 25:561-568.
4. van den Berg E., Dekker J.M., Nijpels G., Kessels R.P., Kappelle L.J., de Haan E.H., et al. Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: The Hoorn study. Dement Geriatr Cogn Disord 2008, 26:261-269.
5. Tournoy J., Lee D.M., Pendleton N., O'Neill T.W., O'Connor D.B., Bartfai G., et al. Association of cognitive performance with the metabolic syndrome and with glycaemia in middle-aged and older European men: The European Male Ageing Study. Diabetes Metab Res Rev 2010, 26:668-676.
6. Laudisio A., Marzetti E., Pagano F., Cocchi A., Franceschi C., Bernabei R., et al. Association of metabolic syndrome with cognitive function: the role of sex and age. Clin Nutr 2008, 27:747-754.
7. van den Berg E., Biessels G.J., de Craen A.J., Gussekloo J., Westendorp R.G. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 2007, 69:979-985.
8. Dik M.G., Jonker C., Comijs H.C., Deeg D.J., Kok A., Yaffe K., et al. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007, 30:2655-2660.
9. Criqui M.H., Barrett-Connor E., Austin M. Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol 1978, 108:367-372.
10. The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group. Prev Med 1976, 5:207-215.
11. Daniels L.B., Laughlin G.A., Clopton P., Maisel A.S., Barrett-Connor E. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol 2008, 52:450-459.
12. Laughlin G.A., von Muhlen D., Daniels L.B., McEvoy L.K., Kritz-Silverstein D., Bergstrom J., et al. Sex differences in the association of Framingham cardiac risk score with cognitive decline. Psychosomatic Med 2011, 73:683-689.
13. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
14. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
15. Tombaugh T.N., McIntyre N.J. The mini-mental state examination: A comprehensive review. J Am Geriatr Soc 1992, 40:922-935.
16. Reitan R.M. The relation of the trail making test to organic brain damage. J Consult Psychol 1955, 19:393-394.
17. Borkowski J., Benton A.L., Spreen O. Word fluency and brain damage. Neuropsychologia 1967, 5:135-140.
18. Buschke H., Fuld P.A. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974, 24:1019-1025.
19. Cukierman T., Gerstein H.C., Williamson J.D. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005, 48:2460-2469.
20. Yaffe K., Weston A.L., Blackwell T., Krueger K.A. The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 2009, 66:324-328.
21. Raffaitin C., Feart C., Le Goff M., Amieva H., Helmer C., Akbaraly T.N., et al. Metabolic syndrome and cognitive decline in French elders: The Three-City Study. Neurology 2011, 76:518-525.
22. Yaffe K., Kanaya A., Lindquist K., Simonsick E.M., Harris T., Shorr R.I., et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004, 292:2237-2242.
23. Yaffe K., Haan M., Blackwell T., Cherkasova E., Whitmer R.A., West N. Metabolic syndrome and cognitive decline in elderly Latinos: Findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 2007, 55:758-762.
24. Cavalieri M., Ropele S., Petrovic K., Pluta-Fuerst A., Homayoon N., Enzinger C., et al. Metabolic syndrome, brain magnetic resonance imaging, and cognition. Diabetes Care 2010, 33:2489-2495.
25. Kanaya A.M., Barrett-Connor E., Gildengorin G., Yaffe K. Change in cognitive function by glucose tolerance status in older adults: A 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 2004, 164:1327-1333.
26. Kloting I., Kovacs P., van den Brandt J. Sex-specific and sex-independent quantitative trait loci for facets of the metabolic syndrome in WOKW rats. Biochem Biophys Res Commun 2001, 284:150-156.
27. Seda O., Tremblay J., Gaudet D., Brunelle P.L., Gurau A., Merlo E., et al. Systematic, genome-wide, sex-specific linkage of cardiovascular traits in French Canadians. Hypertension 2008, 51:1156-1162.
28. Barrett-Connor E.L., Cohn B.A., Wingard D.L., Edelstein S.L. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991, 265:627-631.
29. Huxley R., Barzi F., Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: Meta-analysis of 37 prospective cohort studies. BMJ 2006, 332:73-78.
30. Wannamethee S.G., Papacosta O., Lawlor D.A., Whincup P.H., Lowe G.D., Ebrahim S., et al. Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. Diabetologia 2012, 55:80-87.
31. McNeill A.M., Rosamond W.D., Girman C.J., Golden S.H., Schmidt M.I., East H.E., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005, 28:385-390.
32. Pischon T., Hu F.B., Rexrode K.M., Girman C.J., Manson J.E., Rimm E.B. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis 2008, 197:392-399.
33. Iglseder B., Cip P., Malaimare L., Ladurner G., Paulweber B. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke 2005, 36:1212-1217.
34. Lin H.F., Liu C.K., Liao Y.C., Lin R.T., Chen C.S., Juo S.H. The risk of the metabolic syndrome on carotid thickness and stiffness: Sex and age specific effects. Atherosclerosis 2010, 210:155-159.
35. Boden-Albala B., Sacco R.L., Lee H.S., Grahame-Clarke C., Rundek T., Elkind M.V., et al. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke 2008, 39:30-35.
36. Schmidt R., Fazekas F., Offenbacher H., Dusek T., Zach E., Reinhart B., et al. Neuropsychologic correlates of MRI white matter hyperintensities: A study of 150 normal volunteers. Neurology 1993, 43:2490-2494.
37. Perry M.E., McDonald C.R., Hagler D.J., Gharapetian L., Kuperman J.M., Koyama A.K., et al. White matter tracts associated with set-shifting in healthy aging. Neuropsychologia 2009, 47:2835-2842.
38. Kurland B.F., Johnson L.L., Egleston B.L., Diehr P.H. Longitudinal data with follow-up truncated by death: Match the analysis method to research aims. Stat Sci 2009, 24:211.
39. Ervin R.B. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report 2009, 1-7.
40. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011 2011, Centers for Disease Control and Prevention, Department of Health and Human Services Centers for Disease Control and Prevention, Atlanta, GA.
41. Lorenzo C., Okoloise M., Williams K., Stern M.P., Haffner S.M. The metabolic syndrome as predictor of type 2 diabetes: The San Antonio heart study. Diabetes Care 2003, 26:3153-3159.
42. Malik S., Wong N.D., Franklin S.S., Kamath T.V., L'Italien G.J., Pio J.R., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004, 110:1245-1250.